Physician profile
Glen Davis
NPI 1124168406
$471.64
in general payments reported to CMS, 2019-2025
11 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.52 · 2020: $38.43 · 2023: $108 · 2024: $151 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353 · Education: $15.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.11 |
| Education | $15.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $117.67 | 2023-2025 | Vraylar |
| Novo Nordisk INC | $100.01 | 2019-2024 | Rybelsus, Ozempic |
| Lilly USA, LLC | $59.17 | 2023-2025 | Mounjaro, Jardiance, Trulicity |
| Ucb, INC. | $39.13 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $30.70 | 2023-2025 | Breztri |
| Mallinckrodt Enterprises LLC | $25.85 | 2019 | |
| Pfizer INC. | $25.64 | 2020-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.20 | 2025 | |
| Insulet Corporation | $20.50 | 2025 | Omnipod |
| Opko Pharmaceuticals, LLC | $15.58 | 2023 | Rayaldee |
| Exact Sciences Corporation | $15.19 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glen Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.